πŸ‡ΊπŸ‡Έ FDA
Patent

US 8497381

Antagonists of prostaglandin D2 receptors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8497381 (Antagonists of prostaglandin D2 receptors) held by Panmira Pharmaceuticals, LLC expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/02